Liam Ratcliffe insider trades
Open-market stock purchases and sales by Liam Ratcliffe, Unknown at OnKure Therapeutics, Inc, from SEC Form 4 filings since Oct 24, 2012.
Track record: 0% of 7 scored buys are up 5% or more since purchase, averaging -67%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc | Bought (not open market) | — |
| Jun 18, 2026 | IRON Disc Medicine, Inc | Bought (not open market) | — |
| Jun 9, 2026 | UPB Upstream Bio, Inc | Bought (not open market) | — |
| Jun 4, 2026 | OKUR OnKure Therapeutics, Inc | Bought (not open market) | — |
| Mar 31, 2026 | OKUR OnKure Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- OKUR OnKure Therapeutics, Inc: other filings, last Aug 7, 2026
- IRON Disc Medicine, Inc: other filings, last Jun 18, 2026
- UPB Upstream Bio, Inc: other filings, last Jun 9, 2026
- ELYM Eliem Therapeutics, Inc: other filings, last Jun 26, 2024
- ARVN Arvinas, Inc: 4 buys, 39 sales, last Jun 16, 2022
- PASG Passage BIO, Inc: 3 buys, last May 27, 2021
- UMRX Unum Therapeutics Inc: 1 buy, last Jun 14, 2019
- APTX Aptinyx Inc: 1 buy, last Mar 29, 2019
- EDGE Edge Therapeutics, Inc: other filings, last Aug 14, 2018
- DCPH Deciphera Pharmaceuticals, Inc: 1 buy, last May 17, 2018
- ARRY Array Biopharma Inc: 8 sales, last Oct 23, 2013